Is saas fee expensive?

What “SaaS fee” means (and why it feels expensive in medtech)

SaaS (Software as a Service) means customers pay a recurring subscription (monthly or annual) instead of buying software once. The “fee” typically bundles hosting, security updates, support, and ongoing feature releases.

In medtech and digital health, SaaS can feel expensive because the product is rarely “just software.” The price often includes:

• Compliance work (HIPAA controls, audit logs, access management, vendor risk documentation)
• Clinical workflow fit (role-based permissions, documentation, clinical review, escalation paths)
• Integrations (EHR interfaces, HL7/FHIR mapping, SSO, data exports)
• Validation and change control (especially if your software is regulated as SaMD)

So the right question isn’t “Is the SaaS fee expensive?” but: Expensive compared to what alternative cost or outcome?

How to decide if a SaaS fee is expensive: 4 practical benchmarks

1) Compare to the cost of the problem (not to other apps)

Medtech buyers (clinics, hospitals, device companies) don’t benchmark you against consumer SaaS like Slack. They benchmark you against the current cost of the pain: staff time, adverse events, readmissions, missed charges, delayed throughput, or compliance risk.

A simple way to frame it is a back-of-the-envelope ROI model:

• Value created = (hours saved × loaded hourly cost) + (revenue captured) + (avoidable penalties/risk reduction)
• Total cost = SaaS subscription + implementation + integration + training + internal admin time

If your annual SaaS fee is smaller than a credible fraction of the value created (often buyers want payback within a budgeting cycle), it’s not “expensive”—it’s a lever.

2) Separate subscription from implementation (and ask what’s included)

Many founders accidentally trigger “expensive” reactions by bundling everything into one number. In enterprise healthcare, buyers often expect two buckets:

• Recurring subscription: access + support + updates
• One-time implementation: onboarding, configuration, integrations, data migration, training

If a vendor quotes a high recurring fee but it includes heavy-lift services (integration, custom reporting, security reviews), it may be reasonable. If it’s high and still requires lots of paid add-ons, it may be overpriced.

3) Benchmark against “build vs buy” realistically

In medtech, “we’ll build it ourselves” is common—especially in health systems with informatics teams. But internal builds carry hidden costs: maintenance, security patching, uptime, on-call support, and regulatory documentation if it touches clinical decision-making.

When you compare, include:

• Engineering time (not just initial build—ongoing maintenance)
• Security and compliance overhead (policies, audits, access reviews)
• Integration upkeep (EHR upgrades break interfaces)
• Support burden (tickets, training, new staff onboarding)

If your SaaS fee is lower than the true internal cost to keep the tool safe and working for 2–3 years, it’s likely not expensive.

4) Check if the price matches the buyer and the buying motion

“Expensive” depends on who pays and how they buy:

• Clinician-paid (small practice, individual physician): lower tolerance, needs immediate personal value
• Department budget (radiology, cardiology, ICU): medium tolerance, needs workflow + measurable outcomes
• Hospital/IDN procurement (enterprise): higher tolerance, but requires security review, legal terms, and clear ROI
• Medtech manufacturer (device company): may pay more if it supports regulatory, post-market surveillance, or revenue growth

If you price like enterprise but sell like self-serve, you’ll feel “expensive” even if the value is real.

Medtech-specific reasons SaaS fees run higher (and when that’s justified)

Healthcare SaaS often costs more than general B2B SaaS because the vendor carries extra burden and risk. Higher fees are more defensible when you can point to concrete requirements such as:

• Security and privacy: HIPAA-aligned controls, encryption, audit trails, breach response processes
• Regulatory posture: If your product is Software as a Medical Device (SaMD), your quality system, validation, and change control can increase costs. FDA pathway (510(k), De Novo, PMA) depends on risk and claims; requirements vary.
• Clinical evidence: If you need IRB approval for studies or real-world evidence, timelines and costs increase (varies by institution and protocol).
• Interoperability: EHR integration (HL7/FHIR), SSO, and data governance are expensive to build and maintain.
• Reimbursement workflows: If your product impacts billing, coding, or documentation (e.g., CPT-related workflows), you may need specialized features and auditability.

But higher fees are not justified if you’re charging “healthcare premiums” without delivering healthcare-grade requirements (e.g., no audit logs, weak admin controls, no implementation support).

How to talk about price without losing trust: a simple framing

STEM founders often default to feature-based pricing (“we have X modules”). Healthcare buyers respond better to outcome and risk framing:

1. Define the economic unit: per clinician, per site, per device, per patient monitored, or per study.
2. Quantify the baseline: current time spent, error rate, delays, missed revenue, or compliance exposure.
3. Show the mechanism: how your product changes workflow (not just dashboards).
4. Offer a low-risk pilot: time-boxed evaluation with success criteria (e.g., adoption, time saved, throughput). Enterprise pilots often still require security review and procurement steps.

Also clarify what “good” looks like operationally: implementation timeline, training hours, integration scope, and who owns what. A fee feels expensive when the buyer fears surprise work.

Common pricing traps that make your SaaS fee look expensive

• Charging per user in a workflow product: If nurses, techs, and physicians all need access, per-seat pricing can punish adoption. Consider site-based or volume-based pricing if it fits your unit economics.
• Ignoring procurement reality: Hospitals may require vendor onboarding, security questionnaires, and legal review. If your price is low but your process is heavy, you can still lose.
• Not aligning price with reimbursement: If your value depends on billing capture or CPT-related documentation, you must speak to compliance and auditability—not just “revenue uplift.”
• Overpromising regulatory status: Don’t imply FDA clearance unless you have it. Your claims drive regulatory expectations; pathway and requirements vary.

What to do next

1. Build a one-page ROI model with 3 inputs (time saved, revenue captured, risk reduced) and show payback period; keep assumptions explicit.
2. Pick one pricing metric (per site, per device, per patient, per clinician) that matches how value scales in your workflow.
3. Define your “implementation package” (what’s included, timeline, integration scope) so the subscription doesn’t look like a black box.
4. Run 5 buyer interviews focused on budget owner, procurement steps, and what they consider “expensive” vs “worth it.”
5. Pressure-test your positioning against competitors and internal-build alternatives before you finalize price.